ENTEROLACTIS Trademark
Trademark Overview
On Tuesday, January 28, 2025, a trademark application was filed for ENTEROLACTIS with the United States Patent and Trademark Office. The USPTO has given the ENTEROLACTIS trademark a serial number of 99020631. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, October 14, 2025. This trademark is owned by ALFASIGMA S.P.A.. The ENTEROLACTIS trademark is filed in the Pharmaceutical Products category with the following description:
Dietary supplements; Pharmaceutical products and preparations including live milk enzymes and probiotic enzymes for medical and pharmaceutical use, namely, ENTEROLACTIS containing Lactobacillus paracasei CNCM I-1572; dietary supplement beverage for restoring gut microbiota balance, reducing diarrhea incidence and duration and improving symptoms in irritable bowel syndrome (IBS) for medical use; dietary supplemental drinks in the nature of vitamin beverages; dietary fiber to rebalance intestinal bacterial flora, strengthening the immune system, and assisting digestion; biological nutritional supplements for medical use; probiotic bacteria preparations for medical use
General Information
| Serial Number | 99020631 |
| Word Mark | ENTEROLACTIS |
| Filing Date | Tuesday, January 28, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, October 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Dietary supplements; Pharmaceutical products and preparations including live milk enzymes and probiotic enzymes for medical and pharmaceutical use, namely, ENTEROLACTIS containing Lactobacillus paracasei CNCM I-1572; dietary supplement beverage for restoring gut microbiota balance, reducing diarrhea incidence and duration and improving symptoms in irritable bowel syndrome (IBS) for medical use; dietary supplemental drinks in the nature of vitamin beverages; dietary fiber to rebalance intestinal bacterial flora, strengthening the immune system, and assisting digestion; biological nutritional supplements for medical use; probiotic bacteria preparations for medical use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 28, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ALFASIGMA S.P.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | BOLOGNA 40133
IT |
Trademark Events
| Event Date | Event Description |
| Tuesday, January 28, 2025 | NEW APPLICATION ENTERED |
| Tuesday, January 28, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 28, 2025 | APPLICATION FILING RECEIPT MAILED |
| Saturday, July 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, July 19, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, October 13, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 13, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, July 19, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 8, 2025 | ASSIGNED TO EXAMINER |
